NUFACTOR A SPECIALTY INFUSION COMPANY

Live / Registered — Registered (as of 26 Aug 2025)

What this means for you

Registered since 26 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98503716
Registration number
7911386
Mark type
Stylized text
Filed
16 Apr 2024
Published for opposition
08 Jul 2025
Registered
26 Aug 2025
Attorney of record
Marjorie Witter Norman

Goods and services

  • Class 035 — Advertising and business services: Pharmaceutical services, namely, monitoring of pharmaceuticals, biopharmaceuticals, and plasma products prescribed for patients and assessing side effects, mitigation strategies, response to therapy, and laboratory results for business purposes
  • Class 036 — Insurance and financial services: Providing counseling and consulting in the field of healthcare insurance benefits; providing patient advocacy services regarding healthcare insurance prior approvals, reauthorizations, claims, appeals, and reimbursements in the nature of insurance administration services
  • Class 039 — Transportation and storage services: Delivery of pharmaceuticals, biopharmaceuticals, and plasma products to homes
  • Class 044 — Medical, beauty and agricultural services: Providing medical information; dispensing of pharmaceuticals, namely, providing patients with pharmaceuticals, biopharmaceuticals, and plasma products; medical services, namely, coordinating in-home nursing care and infusion in the nature of intravenous (IV) medication therapy services for patients; prescription refill reminder services; providing online information in the field of health and medicine, namely, information regarding medical prescriptions, therapies, and treatments, to patients and medical staff; Providing online information in the field of health and medicine, namely, information regarding pharmaceutical and therapeutic treatments for infusion patients; Providing online information in the field of health and medicine, namely, information regarding nursing care for infusion patients; monitoring pharmaceuticals, biopharmaceuticals, and plasma products prescribed for patients and assessing side effects, mitigation strategies, response to therapy, and laboratory results in the nature of pharmaceutical consultation

Owner

Prosecution history

  • 26 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 26 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
  • 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 08 Jul 2025 — PUBLISHED FOR OPPOSITION
  • 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 05 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 03 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 03 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 03 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 04 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 04 Mar 2025 — NON-FINAL ACTION E-MAILED
  • 04 Mar 2025 — NON-FINAL ACTION WRITTEN
  • 06 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 06 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 06 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED

View this trademark record on Marksy